Drupal.behaviors.print = function(context) {window.print();window.close();}>
Med BioGene Inks LungExpress Alliance with Precision Therapeutics
March 01, 2011
Med BioGene Inks LungExpress Alliance with Precision Therapeutics
Precision Therapeutics has gained exclusive rights to the LungExpress Dx test.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
UPDATE: Signal Genetics Makes Improved Offer to Market Med BioGene Test
March 23, 2011 / GenomeWeb Daily News
Med BioGene Amends Licensing Deal with Precision; Updates Litigation Status
October 3, 2012 / GenomeWeb Daily News
Med BioGene Shareholders Approve Commercialization Deal with Precision Therapeutics
April 13, 2011 / GenomeWeb Daily News
Med BioGene Accepts Amended Offer from Precision Therapeutics
March 28, 2011 / GenomeWeb Daily News
Signal Genetics Adds Precision Therapeutics to Suit
February 25, 2011 / GenomeWeb Daily News